author-photo

Prisca Lucas

Pfizer

5

Papers

157

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

Bapineuzumab for mild to moderate Alzheimer’s disease in two global, randomized, phase 3 trials

2016 Alzheimer's Research & Therapy
Show All
- Source
- Cite
- Save
Citations (145)
Long-term safety and tolerability of bapineuzumab in patients with Alzheimer’s disease in two phase 3 extension studies

2016 Alzheimer's Research & Therapy
Show All
- Source
- Cite
- Save
Citations (12)
POOLED AMYLOID PET BASELINE DATA FROM THE BAPINEUZUMAB IV PHASE III TRIALS

2016 Alzheimers & Dementia
Show All
- Source
- Cite
- Save
Citations (0)
Safety, tolerability and efficacy of lecozotan SR in patients with mild-to-moderate Alzheimer's disease used as monotherapy or adjunctively with a cholinesterase inhibitor

2012 Alzheimers & Dementia
Show All
- Source
- Cite
- Save
Citations (0)